Ornithine decarboxylase gene is overexpressed in colorectal carcinoma

World Journal of Gastroenterology

Volumn 11, Issue 15, 2005, Pages 2244-2248

  Hu, Hai Yan ^a   Liu, Xian Xi ^a   Jiang, Chun Ying ^a   Lu, Yi ^a   Liu, Shi Lian ^a   Bian, Ji Feng ^a   Wang, Xiao Ming ^a   Geng, Zhao ^a   Zhang, Yan ^a   Zhang, Bing ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Colorectal cancer; Ornithine decarboxylase; RT PCR

Indexed keywords

IMMUNOGLOBULIN G2A; ORNITHINE DECARBOXYLASE; DIAGNOSTIC AGENT; MONOCLONAL ANTIBODY; TUMOR MARKER;

ANIMAL CELL; ARTICLE; CHROMATOGRAPHY; COLORECTAL CANCER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE AMPLIFICATION; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYBRIDOMA; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOLECULAR CLONING; MOUSE; MOUSE STRAIN; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PURIFICATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; COLORECTAL TUMOR; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; ANTIBODIES, MONOCLONAL; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, INBRED BALB C; ORNITHINE DECARBOXYLASE; TUMOR MARKERS, BIOLOGICAL;

EID: 21044431877     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i15.2244     Document Type: Article

References (24)

1. Ries LA, Wingo PA, Miller DS, Howe HL, Weir HK, Rosenberg HM, Vernon SW, Cronin K, Edwards BK. The annual report to the nation on the status of cancer, 1973-1977,with a special section on colorectal cancer. Cancer 2000; 88: 2398-2424
2. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin 2000; 50: 7-33
3. Shu Z. Colorectal cancer. In: Jiefu Wang,ed: Gastrointestinal Surgery. Beijing: People's Medical Publishing House,2000: 920-923
4. McCormick D, Kibbe PJ, Morgan SW. Colon Cancer: Prevention, Diagnosis, Treatment. Gastroenterol Nursing 2002; 25: 204-211
5. Stanley R. Hamilton Mda. Colon Cancer Testing and Screening. Arch Pathol Lab Med 1999; 123: 1027-1029
6. Wallace HM, Caslake R. Polyamines and colon cancer. Eur J Gastroenterol Hepatol 2001; 13: 1033-1039
7. Rich TA, Skibber JM, Ajani JA, Buchholz DJ, Gleary KR, Dubrow RA, Levin B, Lynch PM, Meterissian SH, Roubin LD. Preoperative infusional chemoradiation therapy for stage T3 rectal cancer. Int J Radiat Oncol Biol Phys 1995; 32: 1025-1029
8. Thomas T, Thomas TJ. Polyamine metabolism and cancer. J Cell Mol Med 2003; 7: 113-126
9. Auvinen M, Paasinen A, Andersson LC, Holtta E. Ornithine decarboxylase activity is critical for cell transformation. Nature 1992; 360: 355-358
10. Rozhin J, Wilson PS, Bull AW, Nigro ND. Ornithine decarboxylase activity in rat and human colon. Cancer Res 1984; 44: 3226-3230
11. Liu XX, Fu SJ, Zhao CH, Zhang YY, Luo DC, Lin YQ, Jiang CY, Zhang XT, Xuan YJ. CDC activity and polyamine concentration in colon tumor tissue and peratumor tissue. Zhongguo Gangchangxue Zazhi 1996; 16: 11
12. Canizares F, Salinas J, de las Heras M, Diaz J, Tovar I, Martinez P, Penafiel R. Prognostic value of ornithine decarboxylase and polyamines in human breast cancer: correlation with clinicopathologic parameters. Clin Cancer Res 1999; 5: 2035-2041
13. Hu HY, Liu XX, Jiang CY, Zhang Y, Bian JF, Lu Y, Geng Z, Liu SL, Liu CH, Wang XM, Wang W. Cloning and expression of ornithine decarboxylase gene from human colorectal carcinoma. World J Gastroenterol 2003; 9: 714-716
14. Gerhard W, Braciale TJ, Klinman NR The analysis of the monoclonal immune response to influenza virus. I. Production of monoclonal anti-viral antibodies in vitro. Eur J Immunol 1975; 5: 720-725
15. WHO. Histological typing of intestinal tumors 2nd ed. In: Jass J. R. Sobin L H. eds. nternational histological classifications of tumors: Berlin: Springer-Verlag, 1989
16. Russell DH, Durie BGM. Polyamines and the clinical evauation of patients with cancer. Russell and Durie (editors). New York: Raven Press; 1978: 139-155
17. Montminy MR, Bilezikjian LM. Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene. Nature 1987; 328: 175-178
18. Manzella JM, Rychlik W, Rhoads RE, Hershey JW, Blackshear PJ. Insulin induction of ornithine decarboxylase. Importance of mRNA secondary structure and phosphorylation of eukaryotic initiation factors eIF-4B and eIF-4E. J Biol Chem 1991; 266: 2383-2389
19. Sistonen L, Holtta E, Lehvaslaiho H, Lehtola L, Alitalo K. Activation of the neu tyrosine kinase induces the fos/jun transcription factor complex, the glucose transporter and ornithine decarboxylase. J Cell Biol 1989; 109: 1911-1919
20. Rousseau D, Kaspar R, Rosenwald I, Gehrke L, Sonenberg N. Translation initiation of ornithine decarboxylase and nucleocytoplasmic transport of cyclin D1 mRNA are increased in cells overexpressing eukaryotic initiation factor 4E. Proc Natl Acad Sci USA 1996; 93: 1065-1070
21. Pendeville H, Carpino N, Marine JC, Takahashi Y, Muller M, Martial JA, Cleveland JL. The ornithine decarboxylase gene is essential for cell survival during early murine development. Mol Cell Biol 2001; 21: 6549-6558
22. Love RR, Astrow SH, Cheeks AM, Havighurst TC. Ornithine decarboxylase (ODC) as a prognostic factor in operable breast cancer. Breast Cancer Res Treat 2003; 79: 329-334
23. Linsalata M, Caruso MG, Leo S, Guerra V, D'Attoma B, Di Leo A. Prognostic value of tissue polyamine levels in human colorectal carcinoma. Anticancer Res 2002; 22: 2465-2469
24. Giardiello FM, Hamilton SR, Hylind LM, Yang VW, Tamez P, Casero RA Jr. Ornithine decarboxylase and polyamines in familial adenomatous polyposis. Cancer Res 1997; 57: 199-201